Learn more

American Medical Association: Research Letter: Prevalence of Immunosuppression Among US Adults 2013


Learn more

JAMA Network: Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders


Learn more

Inflammasome activation linked to T-cell dysregulation and poor outcomes in comorbid COVID-19 patients, according to MedStar Georgetown Transplant Institute led study. Study data may explain why COVID-19 patients with clinically recognized predisposing factors like obesity, diabetes, liver, kidney and heart disease have more severe disease


Learn more

The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease


Learn more

Immune Dysfunction in Refractory Sinusitis in a Tertiary Care Setting


Learn more

Immunologic Aging in Adults with Congenital Heart Disease: Does Infant Sternotomy Matter?


Learn more

Cardiovascular abnormalities in primary immunodeficiency diseases


Learn more

Antibiotic resistance in patients with primary immunodeficiency disorders versus immunocompetent patients


Learn more

Chronic Rhinosinusitis—Could Phenotyping or Endotyping Aid Therapy?


Learn more

High‐ and low‐dose oral immunotherapy similarly suppress pro‐allergic cytokines and basophil activation in young children


Learn more

Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children


Learn more

Immune mechanisms of oral immunotherapy


Learn more

Suppression of the immunologic response to peanut during immunotherapy is often transient


Learn more

Immunodeficiency in Newborn Infants


Learn more

Basophil activation test: food challenge in a test tube or specialist research tool?


Learn more

Utility of basophil activation test for monitoring the acquisition of clinical tolerance after oral desensitization to cow’s milk: pilot study